{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:03:17Z","timestamp":1794873797554,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:00:00Z","timestamp":1307491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:00:00Z","timestamp":1307491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Disease remission has become a feasible goal for most rheumatoid arthritis (RA) patients; however, patient-reported symptoms, such as pain, may persist despite remission. We assessed the prevalence of pain in RA patients in remission according to the Disease Activity Score (DAS28-CRP4) and the American College of Rheumatology\/European League Against Rheumatism (ACR\/EULAR) remission criteria.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Data were analyzed from RA patients in the Brigham Rheumatoid Arthritis Sequential Study with data at baseline and 1 year. DAS28 remission was defined as DAS28-CRP4 &lt;2.6. The ACR\/EULAR remission criteria included (a) one or more swollen joints, (b) one or more tender joints, (c) C-reactive protein \u22641 mg\/dl, and (d) patient global assessment score \u22641. Pain severity was measured by using the pain score from the Multi-Dimensional Health Assessment Questionnaire (MDHAQ). The associations between baseline clinical predictors and MDHAQ pain at baseline and 1 year were assessed by using multivariable linear regression.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Among the 865 patients with data at baseline and 1 year, 157 (18.2%) met DAS28-CRP4 remission criteria at both time points. Thirty-seven (4.3%) met the ACR\/EULAR remission criteria at baseline and 1 year. The prevalence of clinically significant pain (MDHAQ pain \u22654) at baseline ranged from 11.9% among patients meeting DAS28-CRP4 remission criteria to none among patients meeting ACR\/EULAR remission criteria. Patient global assessment, MDHAQ function, MDHAQ fatigue, MDHAQ sleep, and arthritis self-efficacy were significantly associated with MDHAQ pain in cross-sectional (<jats:italic>P<\/jats:italic> \u2264 0.0005) and longitudinal analyses (<jats:italic>P<\/jats:italic> \u2264 0.03). Low swollen-joint counts were associated with high MDHAQ pain in longitudinal analyses (<jats:italic>P<\/jats:italic> = 0.02) but not cross-sectional analyses. Other measures of inflammatory disease activity and joint damage were not significantly associated with MDHAQ pain at baseline or at 1 year.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Clinically significant pain continues among a substantial proportion of patients in DAS28 remission but not among those in ACR\/EULAR remission. Among patients in DAS28 remission, patient global assessment, disability, fatigue, sleep problems, and self-efficacy are strongly associated with pain severity at baseline and 1 year, whereas inflammatory disease activity and joint damage are not significantly associated with elevated pain severity at either baseline or 1 year.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3353","type":"journal-article","created":{"date-parts":[[2011,6,9]],"date-time":"2011-06-09T06:43:26Z","timestamp":1307601806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":240,"title":["Pain persists in DAS28 rheumatoid arthritis remission but not in ACR\/EULAR remission: a longitudinal observational study"],"prefix":"10.1186","volume":"13","author":[{"given":"Yvonne C","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L","family":"Frits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Shadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"3113_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/ard.2004.022699","volume":"64","author":"T Heiberg","year":"2005","unstructured":"Heiberg T, Finset A, Uhlig T, Kvien TK: Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis. 2005, 64: 191-195. 10.1136\/ard.2004.022699.","journal-title":"Ann Rheum Dis"},{"key":"3113_CR2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3899\/jrheum.080889","volume":"36","author":"SJ Lee","year":"2009","unstructured":"Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A: Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study. J Rheumatol. 2009, 36: 1611-1617. 10.3899\/jrheum.080889.","journal-title":"J Rheumatol"},{"key":"3113_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/ard.2009.116319","volume":"69","author":"E Keystone","year":"2010","unstructured":"Keystone E, Genovese MC, Klareskog L, Hsia EC, Hall S, Miranda PC, Pazdur J, Bae SC, Palmer W, Xu S, et al: Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study. Ann Rheum Dis. 2010, 69: 1129-1135. 10.1136\/ard.2009.116319.","journal-title":"Ann Rheum Dis"},{"key":"3113_CR4","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1002\/art.23059","volume":"56","author":"E Keystone","year":"2007","unstructured":"Keystone E, Fleischmann R, Emery P, Furst DE, van Vollenhoven R, Bathon J, Dougados M, Baldassare A, Ferraccioli G, Chubick A, et al: Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum. 2007, 56: 3896-3908. 10.1002\/art.23059.","journal-title":"Arthritis Rheum"},{"key":"3113_CR5","first-page":"S50","volume":"22","author":"T Pincus","year":"2004","unstructured":"Pincus T, Sokka T, Kavanaugh A: Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for \"near remission\" of DAS or single measures. Clin Exp Rheumatol. 2004, 22: S50-S56.","journal-title":"Clin Exp Rheumatol"},{"key":"3113_CR6","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1002\/art.21259","volume":"52","author":"PM Welsing","year":"2005","unstructured":"Welsing PM, Fransen J, van Riel PL: Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum. 2005, 52: 2616-2624. 10.1002\/art.21259.","journal-title":"Arthritis Rheum"},{"key":"3113_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1177\/147323001003800402","volume":"38","author":"P Taylor","year":"2010","unstructured":"Taylor P, Manger B, Alvaro-Gracia J, Johnstone R, Gomez-Reino J, Eberhardt E, Wolfe F, Schwartzman S, Furfaro N, Kavanaugh A: Patient perceptions concerning pain management in the treatment of rheumatoid arthritis. J Int Med Res. 2010, 38: 1213-1224.","journal-title":"J Int Med Res"},{"key":"3113_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.080591","volume":"36","author":"F Wolfe","year":"2009","unstructured":"Wolfe F, Michaud K: Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure. J Rheumatol. 2009, 36: 27-33.","journal-title":"J Rheumatol"},{"key":"3113_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/art.24392","volume":"61","author":"LH van Tuyl","year":"2009","unstructured":"van Tuyl LH, Vlad SC, Felson DT, Wells G, Boers M: Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology\/European League Against Rheumatism consensus conference. Arthritis Rheum. 2009, 61: 704-710. 10.1002\/art.24392.","journal-title":"Arthritis Rheum"},{"key":"3113_CR10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","volume":"43","author":"J Fransen","year":"2004","unstructured":"Fransen J, Creemers MC, Van Riel PL: Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford). 2004, 43: 1252-1255. 10.1093\/rheumatology\/keh297.","journal-title":"Rheumatology (Oxford)"},{"key":"3113_CR11","first-page":"S29","volume":"24","author":"J Fransen","year":"2006","unstructured":"Fransen J, van Riel PL: DAS remission cut points. Clin Exp Rheumatol. 2006, 24: S29-S32.","journal-title":"Clin Exp Rheumatol"},{"key":"3113_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keq263","volume":"50","author":"CK Iannaccone","year":"2011","unstructured":"Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA: Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2011, 50: 40-46. 10.1093\/rheumatology\/keq263.","journal-title":"Rheumatology (Oxford)"},{"key":"3113_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL: Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009, 68: 954-960. 10.1136\/ard.2007.084459.","journal-title":"Ann Rheum Dis"},{"key":"3113_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","volume":"63","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH , Funovits J, Aletaha D, Allart CF, Bathon J, Bombardieri S, et al: American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011, 63: 573-586. 10.1002\/art.30129.","journal-title":"Arthritis Rheum"},{"key":"3113_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"3113_CR16","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F: Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 1999, 42: 2220-2230. 10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5.","journal-title":"Arthritis Rheum"},{"key":"3113_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/anr.1780320107","volume":"32","author":"K Lorig","year":"1989","unstructured":"Lorig K, Chastain RL, Ung E, Shoor S, Holman HR: Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989, 32: 37-44. 10.1002\/anr.1780320107.","journal-title":"Arthritis Rheum"},{"key":"3113_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pain.2009.06.024","volume":"146","author":"AS Chappell","year":"2009","unstructured":"Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H: Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain. 2009, 146: 253-260. 10.1016\/j.pain.2009.06.024.","journal-title":"Pain"},{"key":"3113_CR19","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3899\/jrheum.080947","volume":"36","author":"F Wolfe","year":"2009","unstructured":"Wolfe F, Boers M, Felson D, Michaud K, Wells GA: Remission in rheumatoid arthritis: physician and patient perspectives. J Rheumatol. 2009, 36: 930-933. 10.3899\/jrheum.080947.","journal-title":"J Rheumatol"},{"key":"3113_CR20","first-page":"1243","volume":"33","author":"M Soubrier","year":"2006","unstructured":"Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M: Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?. J Rheumatol. 2006, 33: 1243-1246.","journal-title":"J Rheumatol"},{"key":"3113_CR21","first-page":"S45","volume":"24","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Smolen JS: Remission of rheumatoid arthritis: should we care about definitions?. Clin Exp Rheumatol. 2006, 24: S45-S51.","journal-title":"Clin Exp Rheumatol"},{"key":"3113_CR22","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/acr.20005","volume":"62","author":"D Borenstein","year":"2010","unstructured":"Borenstein D, Altman R, Bello A, Chatham W, Clauw DJ, Crofford LJ, Croft J, Hassett A, Kozin F, Pisetsky D, et al: Report of the American College of Rheumatology Pain Management Task Force. Arthritis Care Res (Hoboken). 2010, 62: 590-599.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3113_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/art.22225","volume":"55","author":"W Kievit","year":"2006","unstructured":"Kievit W, Welsing PM, Adang EM, Eijsbouts AM, Krabbe PF, van Riel PL: Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general health. Arthritis Rheum. 2006, 55: 745-750. 10.1002\/art.22225.","journal-title":"Arthritis Rheum"},{"key":"3113_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.berh.2007.02.006","volume":"21","author":"T Pincus","year":"2007","unstructured":"Pincus T, Sokka T: Can Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases?. Best Pract Res Clin Rheumatol. 2007, 21: 733-753. 10.1016\/j.berh.2007.02.006.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3113_CR25","first-page":"695","volume":"31","author":"F Wolfe","year":"2004","unstructured":"Wolfe F, Michaud K: Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol. 2004, 31: 695-700.","journal-title":"J Rheumatol"},{"key":"3113_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00002281-200201000-00009","volume":"14","author":"LA Bradley","year":"2002","unstructured":"Bradley LA, McKendree-Smith NL: Central nervous system mechanisms of pain in fibromyalgia and other musculoskeletal disorders: behavioral and psychologic treatment approaches. Curr Opin Rheumatol. 2002, 14: 45-51. 10.1097\/00002281-200201000-00009.","journal-title":"Curr Opin Rheumatol"},{"key":"3113_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11926-002-0038-5","volume":"4","author":"R Staud","year":"2002","unstructured":"Staud R: Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep. 2002, 4: 299-305. 10.1007\/s11926-002-0038-5.","journal-title":"Curr Rheumatol Rep"},{"key":"3113_CR28","first-page":"2291","volume":"33","author":"F Wolfe","year":"2006","unstructured":"Wolfe F, Rasker JJ: The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol. 2006, 33: 2291-2299.","journal-title":"J Rheumatol"},{"key":"3113_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/ard.2005.037333","volume":"64","author":"H Makinen","year":"2005","unstructured":"Makinen H, Kautiainen H, Hannonen P, Sokka T: Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?. Ann Rheum Dis. 2005, 64: 1410-1413. 10.1136\/ard.2005.037333.","journal-title":"Ann Rheum Dis"},{"key":"3113_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3899\/jrheum.090764","volume":"37","author":"C Lati","year":"2010","unstructured":"Lati C, Guthrie LC, Ward MM: Comparison of the construct validity and sensitivity to change of the visual analog scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis. J Rheumatol. 2010, 37: 717-722. 10.3899\/jrheum.090764.","journal-title":"J Rheumatol"},{"key":"3113_CR31","first-page":"1475","volume":"34","author":"B Bruce","year":"2007","unstructured":"Bruce B, Fries JF, Murtagh KN: Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007, 34: 1475-1479.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3353\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:04:44Z","timestamp":1728385484000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["3113"],"URL":"https:\/\/doi.org\/10.1186\/ar3353","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]},"assertion":[{"value":"20 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R83"}}